Table 2 Previous treatment (N = 36).

From: Efficacy and safety for Apatinib treatment in advanced gastric cancer: a real world study

Treatment No. %
Prior gastrostomy
  Radical surgery 10 27.8%
  Palliative surgery 2 5.6%
  No surgery 24 66.7%
Prior radiotherapy
  Yes 5 13.9%
  No 31 86.1%
Prior chemotherapy
  2 lines 25 69.4%
  3 lines 8 22.2%
  4 lines 2 5.6%
  5 lines 1 2.8%
Prior targeted therapy
  Antiangiogenic therapy 9 25.0%
  Anti-Her2 therapy 8 22.2%
  No targeted therapy 19 52.8%
  1. (Antiangiogenic therapy included bevacizumab or apatinib therapy).